
Stephen Charles Medlin DO FACP
Hematologic Oncology
Founding Director and Endowed Chair of Stem Cell Transplant and Immunotherapies
Join to view full profile
8081 Innovation Park DrLevel 4 - Skyline ClinicFairfax, VA 22031
Phone+1 571-472-1390
Fax+1 571-472-1391
Dr. Medlin is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Missouri-ColumbiaFellowship, Hematology and Medical Oncology, 2006 - 2007
University of Wisconsin Hospitals and ClinicsFellowship, Hematology and Medical Oncology, 2004 - 2006
Marshfield ClinicResidency, Internal Medicine, 2001 - 2004
Des Moines University College of Osteopathic MedicineClass of 2001
Certifications & Licensure
OH State License 2012 - 2028
WI State License 2002 - 2027
IL State License 2019 - 2026
VA State License 2023 - 2026
SD State License Active through 2013
AR State License 2011 - 2012
IA State License 2008 - 2012
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
Clinical Trials
- Fludarabine-based Conditioning for Severe Aplastic Anemia (BMT CTN 0301)
- Blood Stem Cell Transplant With Low Dose Chemotherapy for Relapsed Follicular Non-Hodgkin's Lymphoma (BMT CTN 0701)
- A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2011 Oct 01
Publications & Presentations
PubMed
- Cyclophosphamide for the Treatment of Refractory Immune Effector Cell-Associated Neurotoxicity Syndrome Following CD19-Targeted CAR T-Cell Therapy.Austin Frisch, Loren Marino, Deena Alsaadi, Aditya Kasarabada, Gwen Hua
Journal of Medical Cases. 2026-01-01 - Refractory Epstein-Barr Virus-Negative Diffuse Large B-Cell Lymphoma Post-Transplant Lymphoproliferative Disorder in a Renal Transplant Patient Treated With Bispecific...Austin Frisch, Bobby Se, Eric Martin, Haresh Mani, Stephen Medlin
Journal of Medical Cases. 2026-01-01 - Comparison of intermittent intravenous tacrolimus to continuous tacrolimus in adult allogeneic stem cell transplant recipients.Michael Williams, Zartash Gul, Justin Graff, Brittany Mejaki, Sherjeel Sana
Journal of Oncology Pharmacy Practice. 2025-06-01
Journal Articles
- Safety and Efficacy of Cryopreserved Platelets in Bleeding Patients with ThrombocytopeniaJose A Cancelas, Stephen Medlin, Zbigniew M Szczepiorkowski, Terry B Gernsheimer, Transfusion
Professional Memberships
- Member
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









